Arrigo Francesco Giuseppe Cicero: Redefining the Role of Urate-Lowering Therapy in Cardiovascular Disease
Arrigo Francesco Giuseppe Cicero, Head and Associate Professor of Human Nutrition at Alma Mater Studiorum – University of Bologna and President at SiNut Official, shared a post on LinkedIn about a recent article he and his colleges co-authored published in European Heart Journal – Cardiovascular Pharmacotherapy, adding:
“I am pleased to share our latest review, published in European Heart Journal – Cardiovascular Pharmacotherapy:
‘Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio–renal–metabolic risk modulation’
In this article, we discuss the role of serum uric acid and urate-lowering therapy within the broader cardio–renal–metabolic risk continuum, integrating epidemiological evidence, Mendelian randomization data, pharmacological considerations, and clinical trial findings.
Many thanks to Claudio Borghi and to Federica Fogacci for her outstanding ability to critically re-discuss an established argument.”
Title: Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio–renal–metabolic risk modulation
Authors: Claudio Borghi, Federica Fogacci, Arrigo F G Cicero
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 13, 2026, 16:09Dimitrios Syrengelas: Haemophilia Care Begins With Safe Movement
-
Sep 13, 2026, 15:33Christina (Tina) P.: Antiphospholipid Syndrome After Unprovoked VTE
-
Sep 13, 2026, 15:22Ioana Alexandra Voda: The Story Gets More Time at IFOS Istanbul
-
Sep 13, 2026, 14:52Omar Al Hammadi: Integrating Diabetes and Dyslipidemia in Modern Clinical Care
-
Sep 13, 2026, 14:37Mohammad Zamrood Khan: Hereditary Spherocytosis and Protein C/S Deficiency Case Report Submitted
-
Sep 13, 2026, 14:33Heghine Khachatryan: A Resource-Adapted Approach to Hemophilia Joint Care
-
Sep 13, 2026, 14:23Simon Fletcher: The Unmet Burden of Factor VII Deficiency
-
Sep 13, 2026, 14:10Azusa Nagao: The Evolving Burden of Haemophilia Prophylaxis
-
Sep 13, 2026, 13:50Priya Sriskandarajah: The Challenge of Thrombotic Risk in Myeloproliferative Neoplasms